Chemotherapeutic Drugs Induce PPAR-γ Expression and Show Sequence-Specific Synergy with PPAR-γ Ligands in Inhibition of Non–Small Cell Lung Cancer
2008 · Neoplasia · 47 citations
https://doi.org/10.1593/neo.08134
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
558
Citations
11
h-index
11
i10-index
Anjaiah Srirangam is an academic researcher from Bristol-Myers Squibb (United States). The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer-related Molecular Pathways & RNA modifications and cancer. The author has an h-index of 11, co-authored 21 publications.
https://doi.org/10.1593/neo.08134
https://doi.org/10.1074/jbc.m304616200
Click to start Chat